Ivantis, Inc. is a company dedicated to the development of new and innovative solutions for glaucoma. Current therapies for primary open angle glaucoma (POAG) include eye drops, laser therapy, and surgery. But each of these has its limitations. Glaucoma remains the leading cause of blindness worldwide, in need of better treatment alternatives.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/01/12 | $27,000,000 | Series B |
Ascension Health Ventures Delphi Ventures MemorialCare Innovation Fund | undisclosed |
| 01/13/14 | $14,000,000 | Series B-1 |
Ascension Health Ventures Delphi Ventures EDBI GBS Venture Partners MemorialCare Innovation Fund Vertex Ventures | undisclosed |
| 01/09/17 | $25,000,000 | Series C |
Ascension Health Ventures Delphi Ventures EDBI Foresite Capital MemorialCare Innovation Fund Merieux Developpement RA Capital Management Vertex Ventures | undisclosed |
